The annual cost of diabetes care in this country is rapidly approaching $200 billion, an astonishing figure that has nearly doubled since the beginning of this decade. Dr. Jan Berger, senior vice president and chief clinical officer of the Caremark Corporation, tells host Bruce Japsen that it does not have to be this way. Patients with this potentially deadly disease must work more efficiently in coordination with their physicians toward proper management of care.